(Q33772714)

29 July 2017

1 reference

title

A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression (English)

1 reference

29 July 2017

Nelson JC

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

29 July 2017

published in

Biological Psychiatry

1 reference

29 July 2017

volume

46

1 reference

29 July 2017

issue

9

1 reference

29 July 2017

page(s)

1301-1308

1 reference

Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Predictors of response to amine-specific antidepressants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

THE DIAGNOSIS OF DEPRESSIVE SYNDROMES AND THE PREDICTION OF E.C.T. RESPONSE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Binding of antidepressants to human brain receptors: focus on newer generation compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Do noradrenaline and serotonin differentially affect social motivation and behaviour?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Diagnostic Criteria for Use in Psychiatric Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Predictors of drug response in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

A New Depression Scale Designed to be Sensitive to Change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

The symptoms of major depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Desipramine plasma concentration and antidepressant response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Drug-responsive symptoms in melancholia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

inferred from DOI database lookup

7 January 2021

based on heuristic

(Z)-dimethylamino-1-(4-bromophenyl)-1-(3-pyridyl) propene (h 102/09), a new selective inhibitor of the neuronal 5-hydroxytryptamine uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900173-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00173-0

1 reference

29 July 2017

1 reference